Showing results (221-230 of 273) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2024
Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular CarcinomaDaniel Q Huang, Joseph K Hoang, Rubayet Kamal, et al.
Hepatology International|December 5, 2020
HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohortYasuhito Tanaka, Eiichi Ogawa, Chung-Feng Huang, et al.
Hepatology (Baltimore, Md.)|May 15, 2023
Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phaseDaniel Q Huang, Andrew Tran, Ming-Lun Yeh, et al.
Infectious Diseases and Therapy|April 9, 2025
Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study)Chung-Feng Huang, Jeong Heo, Rong-Nan Chien, et al.
The American Journal of Gastroenterology|October 22, 2019
Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis BYao-Chun Hsu, Grace Lai-Hung Wong, Chien-Hung Chen, et al.
The American Journal of Gastroenterology|December 12, 2025
Long-term effectiveness of tenofovir alafenamide versus entecavir in treatment-naïve chronic hepatitis B: A REAL-B studyJie Li, Joanne Kimiko Liu, Angela Chau, et al.
Hepatology Communications|October 29, 2024
Clinical care guidance in patients with diabetes and metabolic dysfunction-associated steatotic liver disease: A joint consensusJee-Fu Huang, Tien-Jyun Chang, Ming-Lun Yeh, et al.
Journal of Gastroenterology and Hepatology|March 13, 2024
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational studyTyng-Yuan Jang, Po-Cheng Liang, Dae Won Jun, et al.
Pageof 28